This content is restricted.
Brief
On "11/09/2024", the "French National Agency for the Safety of Medicines and Health Products (ANSM)" issued an update regarding "Dive into the ANSM 2023 activity report". The report highlights key moments in 2023, including creating a temporary scientific committee to assess pregnancy pictogram evolution and strengthening GLP-1 monitoring.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested